Gabapentin Tablet, Coated
Product Images NDC 80425-0201

13 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Description (Description)
Chemical structure of gabapentin showing a cyclohexane ring with attached aminomethyl and carboxymethyl groups.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
A line graph depicting mean pain scores over an 8-week period comparing placebo with Gabapentin at 3,600 mg/day. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 9. Gabapentin shows a decreasing pain score trend compared to placebo.*
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
A line graph displaying mean pain score over weeks during a 3-week dose titration period followed by a 4-week fixed dose period. The graph compares placebo, Gabapentin 1,800 mg/day, and Gabapentin 2,400 mg/day treatment groups, showing decreasing pain scores for Gabapentin groups over time.*
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
A bar chart comparing percentage outcomes in two studies. Study 1 shows 12% for placebo (PBO) and 29% for Gabapentin (GBP) 3,600 mg. Study 2 shows 14% for placebo, 32% for GBP 1,800 mg, and 34% for GBP 2,400 mg. Significance markers indicate p-values below 0.01 and 0.001.*
FDA Label Image

Fig 4 (Fig 4)

Fig 4 (Fig 4)
A scatter plot chart illustrating differences (%) on the y-axis against daily dose (mg) on the x-axis for Gabapentin. It compares data points from three studies labeled Study a, Study b, and Study c, each represented by different colored markers, showing varying difference percentages across doses ranging approximately from 600 mg to 1800 mg.*
FDA Label Image

Label 1 (Lable 1)

Label 1 (Lable 1)
Gabapentin 800 mg coated tablets packaging label from Advanced Rx of Tennessee, LLC. The label includes storage instructions, a barcode, lot number, expiration date of 11/3/2023, and comparison to Neurontin with corresponding National Drug Codes (NDC). The label also identifies Westminster Pha as involved with the product.*
FDA Label Image

Label 2 (Lable 2)

Label 2 (Lable 2)
Gabapentin 800 mg coated tablet label from Advanced Rx of Tennessee, LLC. The label includes storage instructions, a barcode, lot number, expiration date (11/3/2023), and references the NDC 80425-0204-02 and source NDC 69367-0347-05. It is packaged in a quantity of 60 tablets.*
FDA Label Image

Label 3 (Label 3)

Label 3 (Label 3)
Gabapentin 600 mg coated tablet packaging label from Advanced Rx of Tennessee, LLC. The label includes storage instructions, a comparison to Neurontin, the NDC numbers, lot number 90GAB600224, and expiration date of 2/18/2024. The label also mentions WESTMINSTER PHA and includes a barcode and QR code.*
FDA Label Image

Label 4 (Label 4)

Label 4 (Label 4)
Gabapentin 600 mg coated tablet packaging label from Advanced Rx of Tennessee, LLC, Nashville, TN. The label includes product name, strength, lot number 120GAB6000224, expiration date 2/18/2024, and NDC information. Barcode and storage instructions at 20-25°C (68-77°F) are also visible.*
FDA Label Image

Gabapentin 800 1 (Gabapentin 800mg 80425 0204 01)

Gabapentin 800 1 (Gabapentin 800mg 80425 0204 01)
Gabapentin 800 mg coated tablet packaging label from Advanced Rx of Tennessee, LLC. The label shows storage instructions (20-25°C), a warning not to transfer the drug to other patients, and barcode information. It also references comparison to Neurontin and includes lot and expiration date details.*
FDA Label Image

Gabapentin 800-2 (Gabapentin 800mg 80425 0204 02)

Gabapentin 800-2 (Gabapentin 800mg 80425 0204 02)
Gabapentin 800 mg coated tablets in a package labeled with the name Gabapentin 800MG TABLET and #60 count. The label shows storage instructions to keep the product at 20°–25°C (68°–77°F), with a caution to prevent reuse of the patient box. The manufacturer is Advanced Rx of Tennessee, LLC, and the medication is compared to Neurontin. The lot number and expiration date (11/3/2023) are also visible on the label.*
FDA Label Image

Gabapentin 800-3 (Gabapentin 800mg 80425 0204 03)

Gabapentin 800-3 (Gabapentin 800mg 80425 0204 03)
Gabapentin 800 mg coated tablet label from Advanced Rx of Tennessee, LLC. The label includes storage instructions (20-25°C), a barcode, NDC numbers for Gabapentin, lot number, and expiration date of 11/3/2023. It also references comparison to Neurontin and is marked Rx Only.*
FDA Label Image

Gabapentin 800-4 (Gabapentin 800mg 80425 0204 04)

Gabapentin 800-4 (Gabapentin 800mg 80425 0204 04)
Gabapentin 800 mg coated tablet label from Advanced Rx of Tennessee, LLC. The label includes storage instructions at 20°-25°C, a barcode, and a comparison reference to Neurontin. It displays the product name, strength, dosage form, and lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.